Tag: Emily Drabant

23andMe In The News

In a flurry of appearances over the course of a few days earlier this month, 23andMe’s CEO Anne Wojcicki articulated again the role personal genetics will play in health care, and what it might mean to have not just a million people genotyped, but millions. “A million people walking around with their ...

Read more

People Powered Research at 23andMe

There are a lot of reasons why Thelma Ackley signed up for 23andMe — she’s fascinated by her ancestry and she's curious about her health — but the main reason is her husband and her six grandchildren. A few years ago her husband Jim, a former engineer, developed Parkinson’s disease. The neurodegenerative ...

Read more

Some Basics About Using 23andMe

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

23andMe’s Parkinson’s Research Featured on NPR

Our Parkinson’s research community got some welcome attention from NPR on Monday just as we are on the cusp of reaching our goal of enrolling 10,000 patients. The piece featured Emily Drabant, PhD, 23andMe’s research manager for our Parkinson’s community, and focused on our model of engaging patients as ...

Read more

23andMe’s Parkinson’s Community is Almost There

23andMe's Emily Drabant, PhD, speaking at a Parkinson's event in Iowa. 23andMe is tantalizingly close to reaching the goal of enrolling 10,000 patients in our Parkinson’s research community. We’re past the 8,000 mark and the pace of enrollment is now more than two-and-a-half times what was a year ago, but ...

Read more

The State of the Science of Parkinson’s Research

Recently, Todd Sherer, CEO of The Michael J. Fox Foundation (MJFF), Brian Fiske, vice president of research programs at MJFF, and Emily Drabant, 23andMe’s research manager for its Parkinson’s community, sat down and took stock of the recent advances in Parkinson’s research. Their conversation centered ...

Read more

Return to top